This project implements a Personalized Closed-Loop Artificial Pancreas system for Type 1 Diabetes (T1D) management. The system uses Reinforcement Learning (RL) to learn optimal continuous insulin dosing strategies for different patient cohorts (children, adolescents, adults) without relying on meal announcements.

RL for insulin dosing in Type-1 Diabetes patients in simglucose using PPO Agents